| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |